Many patients are unaware of factors that influence how they are billed, such as ancillary fees and organizational setups that use parties offsite to interpret imaging studies. In turn, the pricing information patients receive prior to exams is often incomplete. 

High out-of-pocket costs are a growing problem in healthcare, often creating stress and confusion for patients. A new analysis in Circulation: Cardiovascular Quality and Outcomes examined one way that physicians can help. 

Amgen’s newly created subsidiary, Pillartree Limited, will acquire Horizon Therapeutics for $116.50 per share in cash. That’s a premium of 19.7% above the closing price of $97.29 on Dec. 9, 2022.

According to reports, the respiratory physician who treated the patient following her lung cancer diagnosis described her death as “totally avoidable."

Clinicians who routinely manage patients screened for lung cancer with low-dose CT have a new 1-page printout to illuminate evidence-based care pathways when faced with significant but questionably urgent incidental findings.

Epic, the nation’s largest electronic health record system, has launched a new Connection Hub where vendors can interoperate with Epic software.

New research published in Annals of Rheumatic Diseases and Hypertension examined the impact medications for different non-cardiovascular conditions can have on a patient's heart health.

An AI startup has been cleared to market a platform for precisely mapping prostate cancer with 3D visualization so the tumor can be treated without harm to healthy surrounding prostate tissue.